How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Sell
34
ARCC Quote, Financials, Valuation and Earnings
Last price:
$22.17
Seasonality move
:
1.91%
Day range:
$21.62 - $22.24
52-week range:
$19.32 - $23.84
Dividend yield:
8.66%
P/E ratio:
9.05x
P/S ratio:
8.10x
P/B ratio:
1.14x
Volume:
5.4M
Avg. volume:
4.6M
1-year change:
6.46%
Market cap:
$15.2B
Revenue:
$1.7B
EPS (TTM):
$2.45
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $541M | $1.7B | $741M | $1.6B | $1.7B | |
| Revenue Growth (YoY) | -34.35% | 210.17% | -55.84% | 120.78% | 4.4% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $38M | $39M | $38M | $42M | $43M | |
| Other Inc / (Exp) | -$148M | $258M | $24M | -$155M | -$60M | |
| Operating Expenses | $38M | $82M | $86M | $94M | $113M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $503M | $1.6B | $655M | $1.5B | $1.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $19M | $29M | $55M | $20M | $73M | |
| Net Income to Company | $484M | $1.6B | $600M | $1.5B | $1.5B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $484M | $1.6B | $600M | $1.5B | $1.5B | |
| Basic EPS (Cont. Ops) | $1.14 | $3.51 | $1.21 | $2.75 | $2.44 | |
| Diluted EPS (Cont. Ops) | $1.14 | $3.51 | $1.19 | $2.68 | $2.44 | |
| Weighted Average Basic Share | $424M | $446M | $498M | $554M | $624M | |
| Weighted Average Diluted Share | $424M | $446M | $518M | $575M | $624M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $820M | $2B | $1.1B | $2.1B | $2.3B | |
| Revenue (Reported) | $541M | $1.7B | $741M | $1.6B | $1.7B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $820M | $2B | $1.1B | $2.1B | $2.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $369M | $358M | $166M | $444M | $393M | |
| Revenue Growth (YoY) | 89.23% | -2.72% | -53.63% | 167.47% | -11.49% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $9M | $10M | $9M | $9M | $10M | |
| Other Inc / (Exp) | -$170M | -- | $1M | $5M | -$35M | |
| Operating Expenses | -$17M | -$32M | -$26M | $22M | $23M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $386M | $390M | $192M | $422M | $370M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $7M | $8M | $18M | $9M | $13M | |
| Net Income to Company | $378M | $382M | $174M | $413M | $357M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $379M | $382M | $174M | $413M | $357M | |
| Basic EPS (Cont. Ops) | $0.89 | $0.83 | $0.34 | $0.72 | $0.55 | |
| Diluted EPS (Cont. Ops) | $0.89 | $0.83 | $0.34 | $0.70 | $0.55 | |
| Weighted Average Basic Share | $421M | $461M | $516M | $572M | $654M | |
| Weighted Average Diluted Share | $421M | $461M | $536M | $596M | $654M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $494M | $537M | $368M | $566M | $544M | |
| Revenue (Reported) | $369M | $358M | $166M | $444M | $393M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $494M | $537M | $368M | $566M | $544M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $546M | $1.7B | $745M | $1.6B | $1.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $38M | $39M | $38M | $42M | $43M | |
| Other Inc / (Exp) | -$148M | $258M | $24M | -$155M | -$60M | |
| Operating Expenses | $42M | $82M | $90M | $93M | $113M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $504M | $1.6B | $655M | $1.5B | $1.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $19M | $29M | $55M | $20M | $73M | |
| Net Income to Company | $484M | $1.6B | $600M | $1.5B | $1.5B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $485M | $1.6B | $600M | $1.5B | $1.5B | |
| Basic EPS (Cont. Ops) | $1.16 | $3.52 | $1.21 | $2.74 | $2.45 | |
| Diluted EPS (Cont. Ops) | $1.16 | $3.52 | $1.20 | $2.67 | $2.45 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $817M | $2B | $1.1B | $2.1B | $2.3B | |
| Revenue (Reported) | $546M | $1.7B | $745M | $1.6B | $1.7B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $817M | $2B | $1.1B | $2.1B | $2.3B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.7B | $745M | $1.6B | $1.7B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $39M | $38M | $42M | $43M | -- | |
| Other Inc / (Exp) | $258M | $24M | -$155M | -$60M | -- | |
| Operating Expenses | $82M | $90M | $93M | $113M | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.6B | $655M | $1.5B | $1.6B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $29M | $55M | $20M | $73M | -- | |
| Net Income to Company | $1.6B | $600M | $1.5B | $1.5B | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.6B | $600M | $1.5B | $1.5B | -- | |
| Basic EPS (Cont. Ops) | $3.52 | $1.21 | $2.74 | $2.45 | -- | |
| Diluted EPS (Cont. Ops) | $3.52 | $1.20 | $2.67 | $2.45 | -- | |
| Weighted Average Basic Share | $1.8B | $2B | $2.2B | $2.5B | -- | |
| Weighted Average Diluted Share | $1.8B | $2.1B | $2.3B | $2.5B | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2B | $1.1B | $2.1B | $2.3B | -- | |
| Revenue (Reported) | $1.7B | $745M | $1.6B | $1.7B | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2B | $1.1B | $2.1B | $2.3B | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $254M | $372M | $303M | $535M | $635M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $477M | $594M | $483M | $796M | $1.2B | |
| Property Plant And Equipment | $38M | $27M | $20M | $10M | -- | |
| Long-Term Investments | $15.5B | $20B | $21.8B | $22.9B | $26.7B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $16.2B | $20.8B | $22.4B | $23.8B | $28.3B | |
| Accounts Payable | $179M | $316M | $127M | $139M | $406M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $447M | $727M | $356M | $430M | $865M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $9B | $12B | $12.8B | $12.6B | $14.9B | |
| Common Stock | -- | -- | $1M | $1M | $1M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $7.2B | $8.9B | $9.6B | $11.2B | $13.4B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $7.2B | $8.9B | $9.6B | $11.2B | $13.4B | |
| Total Liabilities and Equity | $16.2B | $20.8B | $22.4B | $23.8B | $28.3B | |
| Cash and Short Terms | $254M | $372M | $303M | $535M | $635M | |
| Total Debt | $8.6B | $11.1B | $12.3B | $11.9B | $13.8B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $254M | $372M | $303M | $535M | $635M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $477M | $594M | $483M | $796M | $1.2B | |
| Property Plant And Equipment | $38M | $27M | $20M | -- | -- | |
| Long-Term Investments | $15.5B | $20B | $21.8B | $22.9B | $26.7B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $16.2B | $20.8B | $22.4B | $23.8B | $28.3B | |
| Accounts Payable | $179M | $316M | $127M | $139M | $406M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $447M | $727M | $356M | $430M | $865M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $9B | $12B | $12.8B | $12.6B | $14.9B | |
| Common Stock | -- | -- | $1M | $1M | $1M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $7.2B | $8.9B | $9.6B | $11.2B | $13.4B | |
| Total Liabilities and Equity | $16.2B | $20.8B | $22.4B | $23.8B | $28.3B | |
| Cash and Short Terms | $254M | $372M | $303M | $535M | $635M | |
| Total Debt | $8.6B | $11.1B | $12.3B | $11.9B | $13.8B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $484M | $1.6B | $600M | $1.5B | $1.5B | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$26M | $14M | -$34M | -$60M | -$45M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$580M | -$2.5B | -$1.4B | $511M | -$2.1B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$679M | -$694M | -$912M | -$1B | -$1.1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $8.3B | $19.4B | $8B | $5.2B | $13.2B | |
| Long-Term Debt Repaid | -$6.7B | -$16.8B | -$6.8B | -$5.6B | -$11B | |
| Repurchase of Common Stock | -$100M | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $730M | $2.6B | $1.2B | -$284M | $2.4B | |
| Beginning Cash (CF) | $176M | $326M | $486M | $337M | $564M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $150M | $160M | -$149M | $227M | $296M | |
| Ending Cash (CF) | $326M | $486M | $337M | $564M | $860M | |
| Levered Free Cash Flow | -$580M | -$2.5B | -$1.4B | $511M | -$2.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $373M | $211M | $278M | $449M | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $44M | $18M | -$1M | $10M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $489M | $481M | $872M | -$21M | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$166M | -$208M | -$261M | -$270M | -- | |
| Special Dividend Paid | -- | $30K | -- | -- | -- | |
| Long-Term Debt Issued | $3.2B | $1.8B | $1B | $2.4B | -- | |
| Long-Term Debt Repaid | -$3.7B | -$2.3B | -$2.1B | -$2.2B | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$459M | -$253M | -$832M | $34M | -- | |
| Beginning Cash (CF) | $326M | $486M | $337M | $564M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $30M | $228M | $40M | $13M | -- | |
| Ending Cash (CF) | $356M | $714M | $377M | $577M | -- | |
| Levered Free Cash Flow | $489M | $481M | $872M | -$21M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $484M | $1.6B | $600M | $1.5B | $1.5B | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$26M | $14M | -$34M | -$60M | -$45M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$580M | -$2.5B | -$1.4B | $511M | -$2.1B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$679M | -$694M | -$912M | -$1B | -$1.1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $8.3B | $19.4B | $8B | $5.2B | $13.2B | |
| Long-Term Debt Repaid | -$6.7B | -$16.8B | -$6.8B | -$5.6B | -$11B | |
| Repurchase of Common Stock | -$100M | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $730M | $2.6B | $1.2B | -$284M | $2.4B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $150M | $160M | -$149M | $227M | $296M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$580M | -$2.5B | -$1.4B | $511M | -$2.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $373M | $211M | $278M | $449M | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $44M | $18M | -$1M | $10M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $489M | $481M | $872M | -$21M | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$166M | -$208M | -$261M | -$270M | -- | |
| Special Dividend Paid | -- | $30K | -- | -- | -- | |
| Long-Term Debt Issued | $3.2B | $1.8B | $1B | $2.4B | -- | |
| Long-Term Debt Repaid | -$3.7B | -$2.3B | -$2.1B | -$2.2B | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$459M | -$253M | -$832M | $34M | -- | |
| Beginning Cash (CF) | $326M | $486M | $337M | $564M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $30M | $228M | $40M | $13M | -- | |
| Ending Cash (CF) | $356M | $714M | $377M | $577M | -- | |
| Levered Free Cash Flow | $489M | $481M | $872M | -$21M | -- | |
Get ARCC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ARCC
Sector
P/E ratio
9.05x
11.44x
PEG ratio
0.71x
0.38x
P/B ratio
1.14x
1.07x
Price / LTM sales
8.10x
2.47x
Growth Metrics
ARCC
Sector
Revenue growth
-11.49%
6.9%
Earnings growth
-21.43%
7.04%
Revenue (5-year growth)
15.69%
5.27%
Earnings forecast
$0.54
$0.57
Profitability
ARCC
Sector
Profitability FY 2025
--
$159.4M
Return on invested capital
6.06%
5.51%
Return on assets
5.88%
0.99%
Return on equity
12.36%
9.5%
Earnings Date
Last Earnings Date
Feb
5
Next Earnings Date
May
1
Estimated Next Earnings Date
May
7
Balance Sheet
ARCC
Sector
Total cash
$635M
$471.6M
Short term investments
--
$263.5M
Total assets
$28.3B
$4.4B
Long term debt
$13.8B
$343.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Buy
80
CORT alert for Apr 1
Corcept Therapeutics [CORT] is up 109.21% over the past day.
Sell
47
RGC alert for Apr 1
Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.
Buy
74
COOP alert for Apr 1
Mr. Cooper Group [COOP] is up 14.4% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
